We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

1 hedge funds and large institutions have $1.61M invested in Derma Sciences, Inc. Common Stock (DE) in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 47

98% less funds holding

Funds holding: 52 → 1 (-51)

98% less capital invested

Capital invested by funds: $87.2M → $1.61M (-$85.6M)

Holders
1
Holders Change
-51
Holders Change %
-98.08%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
47
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FPF
FNY Partners Fund
New York
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$19.5M
2
Franklin Resources
Franklin Resources
California
-$13.9M
3
BC
Broadfin Capital
New York
-$13.3M
4
Jennison Associates
Jennison Associates
New York
-$7.34M
5
GIM
Granahan Investment Management
Massachusetts
-$5.97M

DSCI Hedge Fund Activity: Q1 2017 in Review

1 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q1 2017, worth a combined $1.61M — down 98% from $87.2M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of DSCI and 1 opened new positions — a net loss of 46 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was FNY Partners Fund, opening a new position worth an estimated $1.54M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $19.5M sold.

  • 1 institutional investor held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q1 2017, down from 52 in Q4 2016.
  • Funds reported $1.61M of Derma Sciences, Inc. Common Stock (DE) stock for Q1 2017, down 98% quarter-over-quarter.
  • 1 fund opened new Derma Sciences, Inc. Common Stock (DE) positions in Q1 2017 and 47 closed out, a net change of -46 holders.
  • The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q1 2017 was FNY Partners Fund, an estimated $1.54M added.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q1 2017 was Baker Bros. Advisors, an estimated $19.5M sold.

Based on aggregated 13F filings for Q1 2017.